Font Size: a A A
Keyword [HER2-positive]
Result: 21 - 40 | Page: 2 of 6
21. Prognostic Analysis Of Targeted Therapy On T1 Stage HER-2 Positive Breast Cancer
22. The Anti-proliferative Effect And Mechanisms Of Metformin On Human HER2 Positive Gastric Cancer
23. Activation Of PI3K/AKT Pathway Promotes Trastuzumab Resistance In HER2-positive Gastric Cancer
24. Endocytic Mechanisms Of The Antibody-Drug Conjugates Targeting HER2-Positive Breast Cancer Cell
25. Study On Prognostic Indicators Of Breast Cancer
26. Experimental Study In Construction And Bioassay Of The Specific Dual-Function MR Molecular Probe Against HER2 Positive Prostate Cancer Cells
27. Down-Regulation Of Filamin A Expression Impacts Biological Behaviour Of HER2 Positive Breast Cancer Cells
28. PPT Induces HER2-Positive Breast Cancer Cells Apoptosis And Related Mechanism Research
29. Circulating-Free DNA Mutation Associated With Response Of Targeted Therapy In HER2-positive Metastatic Breast Cancer
30. The Combination Effect Of Trastuzumab And Oxaliplatin On Cell Proliferation And Viability In HER2-positive Gastric Cancer
31. Retrospective Study Of Trastuzumab Combined With Chemotherapy In The Treatment Of HER2-positive Advanced Gastric Cancer Clinical Efficacy,Safety And Treatment Before And After The HER2 State And Drug Resistance Gene
32. High Plasma Fibrinogen Is Correlated With Poor Response To Trastuzumab Treatment In HER2 Positive Breast Cancer
33. The HSP90 Inhibitor Ganetespib Synergizes With The Lapatinib In HER2-positive Breast Cancers
34. The Synergetic Efficacy And Mechanism Of NVP-BEZ235 And STA-9090 Against HER2-positive Breast Cancer Cell Lines
35. The Mechanism Study Of The NRG1/HER3 Activation In The Primary Resistance Of HER2-positive Breast Cancer To Trastuzumab
36. JWA Regulates The Molecular Mechanism And Clinical Significance Of HER2-positive Gastric Cancer Cell Migration
37. Correlation Between Ultrasound And Mammography Features And HER2-positive Primary Breast Cancer
38. The HER4-YAP1 Axis Promotes Trastuzumab Resistance In HER2 Positive Gastric Cancer By Inducing EMT Transition
39. Chk1 Activation Regulates Sensitivity Of Lapatinib In HER2-positive Gastric Cancer Cells
40. The Exploration Of Prognostic Factors And Predictive Factors For Response To Neoadjuvant Therapy In Early-stage Breast Cancer
  <<First  <Prev  Next>  Last>>  Jump to